Development of Radiomic-Based Model to Predict Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.

Tankyevych, Olena; Trousset, Flora; Latappy, Claire; Berraho, Moran; Dutilh, Julien; Tasu, Jean Pierre; Lamour, Corinne; Cheze Le Rest, Catherine

Tankyevych, Olena; Trousset, Flora; Latappy, Claire; Berraho, Moran; Dutilh, Julien; Tasu, Jean Pierre; Lamour, Corinne; Cheze Le Rest, Catherine.

Afiliación

Tankyevych O; Nuclear Medicine Department, Poitiers University Hospital, 86000 Poitiers, France.
Trousset F; LaTIM, INSERM, UMR 1101, 29200 Brest, France.
Latappy C; Nuclear Medicine Department, Poitiers University Hospital, 86000 Poitiers, France.
Berraho M; Nuclear Medicine Department, Poitiers University Hospital, 86000 Poitiers, France.
Dutilh J; Nuclear Medicine Department, Poitiers University Hospital, 86000 Poitiers, France.
Tasu JP; Oncology Department, Poitiers University Hospital, 86000 Poitiers, France.
Lamour C; LaTIM, INSERM, UMR 1101, 29200 Brest, France.
Cheze Le Rest C; Medical School, University of Poitiers, 86000 Poitiers, France.

Cancers (Basel) ; 14(23)2022 Nov 30.

Article en En | MEDLINE | ID: mdl-36497415

Palabras clave

NSCLC; PET/CT; durable clinical benefit; immunotherapy; radiomics; response to therapy; survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google